EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 28 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,000 | -91.7% | 3,828 | -79.5% | 0.00% | – |
Q3 2021 | $24,000 | -27.3% | 18,655 | -23.4% | 0.00% | – |
Q2 2021 | $33,000 | +13.8% | 24,355 | +51.3% | 0.00% | – |
Q1 2021 | $29,000 | -67.4% | 16,101 | -53.3% | 0.00% | – |
Q4 2020 | $89,000 | +196.7% | 34,500 | +430.8% | 0.00% | – |
Q3 2020 | $30,000 | – | 6,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 245,000 | $1,727,000 | 0.80% |
Knoll Capital Management, LLC | 53,839 | $380,000 | 0.11% |
Financial Architects, Inc | 4,300 | $30,000 | 0.01% |
C WorldWide Group Holding A/S | 45,100 | $318,000 | 0.01% |
GEODE CAPITAL MANAGEMENT, LLC | 15,864 | $111,000 | 0.00% |
BlackRock Investment Management, LLC | 489 | $3,000 | 0.00% |
CITIGROUP INC | 6 | $0 | 0.00% |
MORGAN STANLEY | 1,010 | $7,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $243,000 | 0.00% |
Tower Research Capital LLC (TRC) | 200 | $1,000 | 0.00% |